Actively Recruiting
A Novel Rehabilitation Approach: Dyadic Strategy Training for Stroke Survivors and Their Caregivers
Led by Taipei Medical University · Updated on 2024-07-03
138
Participants Needed
1
Research Sites
199 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to examine the efficacy of a newly developed dyad-focused strategy training intervention on enhancing participation of stroke survivors and their caregivers. To address this purpose, a single-blinded, parallel-group randomized controlled trial will be implemented to assess the efficacy of the dyad-focused strategy training intervention in comparison to the control group. An expected sample of 138 stroke survivor-caregiver dyads will be recruited from our collaborative hospitals in Northern Taiwan. Data will be analyzed using multiple linear regression models and mixed-effects regression models. Qualitative in-depth interviews with participants, caregivers, and therapists will be conducted following the intervention. Findings of this study will provide important evidence on whether this newly-developed program has immediate and long-term effect on improving and maintaining participation for both stroke survivors and their caregivers. These findings will together support the application of the dyad-focused strategy training intervention in rehabilitation practice and inform future study development.
CONDITIONS
Official Title
A Novel Rehabilitation Approach: Dyadic Strategy Training for Stroke Survivors and Their Caregivers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Stroke survivors aged 20 years and older
- Diagnosed with a first-time stroke within the past two years
- Speak Mandarin
- Have an identified primary caregiver who provides care or assistance
- Able to provide informed consent
- Family caregivers aged 20 years and older
- Speak Mandarin
- Recognized by the survivor as the primary caregiver
- Available to participate in the intervention sessions with the survivor
- Able to provide informed consent
You will not qualify if you...
- Either survivor or caregiver requires significant medical treatment (e.g., chemotherapy, radiation therapy, or dialysis) that impedes participation
- Severe aphasia
- Unable to participate in a 1-hour discussion session
- Diagnosis of dementia, major depressive disorder, substance use, or other psychiatric disorders that impede participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Taipei Medical University
Taipei, Taiwan
Actively Recruiting
Research Team
F
Feng-Hang Chang, Sc.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here